 |
bispecific antibody (monoclonmal antibody) |
|---|---|
| Trade Name | |
| Orphan Indication | HER2-expressing adenocarcinoma of the esophagus |
| USA Market Approval | USA |
| USA Designation Date | 2013-08-08 00:00:00 |
| Sponsor | Merrimack Pharmaceuticals, Inc.;1 Kendall Square, Suite B7201;Cambridge, Massachusetts, 02139 |
